ʻSensitizingʼ Test Paradigms: Study Design.
收藏NIAID Data Ecosystem2026-03-08 收录
数据链接：
官方服务：
资源简介：
△ Objectives related to the specific perspectives of the review. † ratio of placebo-treated vs. naloxone-treated was 0.5. # study design is for remifentanil-placebo infusions. For explanation of abbreviations, please refer to legend Table 1. ʻSensitizingʼ Test Paradigms: Study Design.
创建时间：
2015-06-01
